PL1629844T5 - Długoterminowy system dostarczania leku z kontrolowanym początkowym wyrzutem - Google Patents

Długoterminowy system dostarczania leku z kontrolowanym początkowym wyrzutem

Info

Publication number
PL1629844T5
PL1629844T5 PL04396049T PL04396049T PL1629844T5 PL 1629844 T5 PL1629844 T5 PL 1629844T5 PL 04396049 T PL04396049 T PL 04396049T PL 04396049 T PL04396049 T PL 04396049T PL 1629844 T5 PL1629844 T5 PL 1629844T5
Authority
PL
Poland
Prior art keywords
delivery system
initial burst
core
controlled initial
longterm
Prior art date
Application number
PL04396049T
Other languages
English (en)
Polish (pl)
Other versions
PL1629844T3 (pl
Inventor
Teppo Riihimäki
Original Assignee
Bayer Schering Pharma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34932022&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1629844(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Schering Pharma Oy filed Critical Bayer Schering Pharma Oy
Publication of PL1629844T3 publication Critical patent/PL1629844T3/pl
Publication of PL1629844T5 publication Critical patent/PL1629844T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Communication Control (AREA)
  • Adjustment And Processing Of Grains (AREA)
  • Vending Machines For Individual Products (AREA)
  • Materials For Medical Uses (AREA)
  • Selective Calling Equipment (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL04396049T 2004-07-13 2004-07-13 Długoterminowy system dostarczania leku z kontrolowanym początkowym wyrzutem PL1629844T5 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04396049A EP1629844B2 (en) 2004-07-13 2004-07-13 A longterm delivery system with controlled initial burst

Publications (2)

Publication Number Publication Date
PL1629844T3 PL1629844T3 (pl) 2008-02-29
PL1629844T5 true PL1629844T5 (pl) 2012-10-31

Family

ID=34932022

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04396049T PL1629844T5 (pl) 2004-07-13 2004-07-13 Długoterminowy system dostarczania leku z kontrolowanym początkowym wyrzutem

Country Status (23)

Country Link
US (1) US7850986B2 (da)
EP (1) EP1629844B2 (da)
JP (1) JP4881861B2 (da)
KR (1) KR20070035032A (da)
CN (1) CN1984639A (da)
AT (1) ATE372772T1 (da)
AU (1) AU2005261682B2 (da)
BR (1) BRPI0513295A (da)
CA (1) CA2569542C (da)
DE (1) DE602004008912T3 (da)
DK (1) DK1629844T4 (da)
ES (1) ES2293193T5 (da)
IL (1) IL179846A (da)
MX (1) MX2007000433A (da)
NO (1) NO334931B1 (da)
NZ (1) NZ551823A (da)
PL (1) PL1629844T5 (da)
PT (1) PT1629844E (da)
RU (1) RU2412693C2 (da)
SI (1) SI1629844T1 (da)
UA (1) UA91337C2 (da)
WO (1) WO2006005794A1 (da)
ZA (1) ZA200610473B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1629844B2 (en) 2004-07-13 2012-04-18 Bayer Schering Pharma Oy A longterm delivery system with controlled initial burst
AU2005325213B2 (en) * 2004-08-04 2010-10-07 Evonik Operations Gmbh Methods for manufacturing delivery devices and devices thereof
US8124601B2 (en) * 2007-11-21 2012-02-28 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
JP5502751B2 (ja) 2007-12-20 2014-05-28 エボニック コーポレイション 低残留溶媒濃度を有する微粒子を調製するためのプロセス
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
RU2429017C1 (ru) * 2010-04-05 2011-09-20 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Антиагрегантная активация в эксперименте in vitro
RU2428205C1 (ru) * 2010-04-05 2011-09-10 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Способ стимуляции условно-рефлекторной деятельности в модульном устройстве
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
WO2013013172A1 (en) * 2011-07-20 2013-01-24 The University Of Utah Research Foundation Intravaginal devices for drug delivery
RU2669395C2 (ru) 2012-01-18 2018-10-11 Волдвайд Инновейтив Хелскэа, Инк. Изменяемая окклюзивная повязка
AR089765A1 (es) 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN105310974B (zh) * 2014-08-01 2019-08-23 山东绿叶制药有限公司 罗替戈汀及其衍生物或其药用盐的植入剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832252A (en) 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device
NZ217844A (en) 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
ATE86484T1 (de) 1987-08-08 1993-03-15 Akzo Nv Kontrazeptives implantat.
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
RU2088166C1 (ru) * 1993-08-10 1997-08-27 Педдер Валерий Викторович Способ контрацепции и устройство для его осуществления
DE69534780T2 (de) 1994-04-08 2006-10-05 Qlt Usa Inc., Fort Collins Flüssige Zusammensetzungen zur Arzneistoffabgabe
US5492947A (en) * 1994-06-23 1996-02-20 Aspen Research Corporation Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative
GB2290964A (en) 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
FI97947C (fi) 1994-09-27 1997-03-25 Leiras Oy Menetelmä lääkepreparaatin valmistamiseksi
GB9522403D0 (en) † 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
WO1999061062A1 (en) † 1998-05-29 1999-12-02 Massachusetts Institute Of Technology Cyclodextrin complexes
DE19830651A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
CA2380111A1 (en) 1999-08-03 2001-02-08 Smith & Nephew, Inc. Controlled release implantable devices
PT1248596E (pt) * 2000-01-11 2007-06-21 Bertex Pharma Gmbh Kit para implantações contendo uma fase de veículo e um solvente
US6299894B1 (en) 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
WO2002032433A1 (en) 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
IL157771A0 (en) * 2001-03-27 2004-03-28 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of an antimicrobial agent
CN1210079C (zh) 2001-04-25 2005-07-13 上海市计划生育科学研究所 阴道环制剂及其应用
PL367961A1 (en) * 2001-08-31 2005-03-07 Schering Oy Drug delivery system
US8404272B2 (en) * 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
ES2442675T3 (es) † 2003-07-10 2014-02-12 Warner Chilcott (Ireland) Limited Dispositivos intravaginales de suministro de fármacos
US8481079B2 (en) * 2004-03-24 2013-07-09 Merck Sharp & Dohme B.V. Drug delivery system based on polyethylene vinylacetate copolymers
EP1629844B2 (en) 2004-07-13 2012-04-18 Bayer Schering Pharma Oy A longterm delivery system with controlled initial burst

Also Published As

Publication number Publication date
NO334931B1 (no) 2014-07-14
BRPI0513295A (pt) 2008-05-06
NO20070805L (no) 2007-02-12
DE602004008912D1 (de) 2007-10-25
ATE372772T1 (de) 2007-09-15
RU2006145900A (ru) 2008-06-27
US20080031922A1 (en) 2008-02-07
AU2005261682A1 (en) 2006-01-19
CA2569542C (en) 2012-10-09
UA91337C2 (ru) 2010-07-26
MX2007000433A (es) 2007-03-07
JP2008506672A (ja) 2008-03-06
US7850986B2 (en) 2010-12-14
NZ551823A (en) 2008-07-31
EP1629844A1 (en) 2006-03-01
ZA200610473B (en) 2008-06-25
DE602004008912T2 (de) 2008-06-05
CA2569542A1 (en) 2006-01-19
HK1086751A1 (en) 2006-09-29
AU2005261682B2 (en) 2010-02-11
IL179846A (en) 2012-07-31
SI1629844T1 (sl) 2007-12-31
ES2293193T3 (es) 2008-03-16
JP4881861B2 (ja) 2012-02-22
RU2412693C2 (ru) 2011-02-27
IL179846A0 (en) 2007-05-15
DK1629844T3 (da) 2007-10-15
EP1629844B2 (en) 2012-04-18
PL1629844T3 (pl) 2008-02-29
ES2293193T5 (es) 2012-06-13
DE602004008912T3 (de) 2012-09-13
EP1629844B1 (en) 2007-09-12
DK1629844T4 (da) 2012-05-29
KR20070035032A (ko) 2007-03-29
WO2006005794A1 (en) 2006-01-19
PT1629844E (pt) 2007-10-17
CN1984639A (zh) 2007-06-20

Similar Documents

Publication Publication Date Title
NO20070805L (no) Medikamentavleveringssystem.
GB2433765B (en) Control systems and methods for active controlled bottomhole pressure systems
EP1733513A4 (en) METHOD AND SYSTEM FOR CONTROLLING THE EXCHANGE OF MESSAGES RELATING TO VEHICLES
WO2003028660A3 (en) Drug delivery devices and methods
WO2008039319A3 (en) Injection of therapeutic into porous regions of a medical device
DE60100098D1 (de) Regler, kabinendruckregelsystem und -verfahren
WO2008039979A3 (en) System and method for controlling respiratory therapy based on detected respiratory events
DE50200579D1 (de) Kraftstoffsystem, verfahren zum betreiben des kraftstoff-systems, computerprogramm sowie steuer- und/oder regelgerät zur steuerung des kraftstoffsystems
WO2007146049A3 (en) Morphology profiles for control of agent release rates from polymer matrices
AU2003237402A1 (en) Fluid delivery system with closed-loop flow control and method
WO2006084164A3 (en) Gastric retention and controlled release delivery system
DE60040173D1 (de) Präsenz- und sitzungsbehandlungsinformationen
WO2001052833A8 (en) Compositions for delivery of a cortisol antagonist
EP1645253A3 (en) Cryogenic chamber for systemic cryogenic treatment
TW200631496A (en) One step fire ant control
WO2008005686A8 (en) Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye
WO2008083184A3 (en) Two-way communication for control of an entertainment device
HK1046367A1 (zh) 治疗过敏和炎症症状
GB2416602B (en) System and Method for Open-loop or Closed-loop Control of the Operating Processes in a Vehicle
GB2414086B (en) Vibraion controller for active vibration insulators and method for controlling vibration for the same
EP1738154A4 (en) LIGHT ACCESS CONTROL SYSTEM AND METHOD
FR2894562B1 (fr) Dispositif de fourniture d'oxygene a des occupants d'un aeronef et organe de regulation de pression pour un tel dispositif
GB0504849D0 (en) Call device, call control system, call management system, and call control method
PT2062569E (pt) Sistema de administração vaginal
EP1693062A3 (en) Androgen receptor-dependent gene expression control